The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

Today's label printers range from small desktop units for file-folder paper labels to industrial-grade ones for labeling cables with plastic strips. Here's how to pick the right labeler ...

Harnessing the Power of Mullein, Elderberry, and Mint-This Liquid Lung Support Supplement Clears Airways and Restores Lung Vitality.Sherida ...

During a live event, Payal D. Shah, MD, discusses the case of a woman with metastatic breast cancer and the data for ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Certain behaviors we now recognize as symptoms of specific conditions used to be written off as personality traits, but now that we see things differently, they are labeled signs of mental illness ...

Amidst this rapidly evolving landscape, white label AI tools have become pivotal for companies seeking to harness the power of AI without the extensive resources typically required for developing such ...

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

Q4 2024 Earnings Call Transcript March 25, 2025 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0 ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...